Tin tức & Cập nhật

Chỉ hiển thị Multimedia
Psoriasis patients with overweight, obesity may need higher vunakizumab dosage

Psoriasis patients with overweight, obesity may need higher vunakizumab dosage

14 Oct 2024 bởiJairia Dela Cruz

In the treatment of moderate-to-severe psoriasis, patients with overweight or obesity appear to have a diminished response to vunakizumab compared with those who have lower BMIs, according to a post hoc subgroup analysis of a phase III trial.

14 Oct 2024
Ebdarokimab works wonders for patients with plaque psoriasis

Ebdarokimab works wonders for patients with plaque psoriasis

14 Oct 2024 bởiStephen Padilla

A recent study has shown the safety and efficacy of AK 101 (ebdarokimab) in the treatment of patients with plaque psoriasis, achieving ≥75-percent improvement in Psoriasis Area and Severity Index (PASI 75) and Static Physicians Global Assessment (sPGA) 0/1 response.

14 Oct 2024